Carlyle buys stake in pharma firm Ambio

The private equity firm plans to help the pharmaceutical firm expand in China.

Carlyle buys stake in pharma firm Ambio

The Carlyle Group said on Monday it has acquired a significant minority stake in North Augusta, South Carolina-headquartered Ambio Holdings from specialist healthcare fund MVM Partners.

Founded in 2007 by Chris Bai, Ambio develops and manufactures peptide active pharmaceutical ingredients.

Both target and buyer hope the deal will be a first step towards expansion in China, where a burgeoning middle class and disquiet over a dysfunctional medical system are creating a host...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Click for more on: carlyle | private equity | health | china | acquisitions

Print Edition

FinanceAsia Print Edition